Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Powerful Sedatives Overprescribed to Elderly: Study January 2, 2015 Martha Garcia Add Your Comments New research suggests that certain sedatives, such as Xanax and Valium, are often over-prescribed for elderly patients, placing them at an increased risk of impaired mental faculties, falls, addiction and withdrawal symptoms. In a study published in the medical journal JAMA Psychiatry on December 17, researchers examined a class of sedative drugs known as benzodiazepines, finding that they are widely overprescribed by primary care doctors, especially among older patients. Researchers examined data from the LifeLink LRX Longitudinal Prescription database in 2008, which includes information from more than 60% of all retail pharmacies in the United States. The study found that more than five percent of adults in the U.S. ages 18 to 80 use benzodiazepines, like Valium and Xanax, and use increased in the elderly and among women. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Overall, nearly one-third of older adults used tranquilizers, mostly women. Researchers say the findings are especially surprising considering benzodiazepines are a group of drugs which doctors typically say should not be prescribed for long-term use, particularly in the elderly. While use for younger age groups was noted, it increased with age. About three percent of patients 18 to 35 and five percent of patients 36 to 50 used benzodiazepines in 2008. More than seven percent of patients 51 to 64 years of age and nearly nine percent of patients aged 65 to 80 regularly used drugs like Valium. The report revealed more than six percent of men and nearly 12% of women aged 60 to 80 used drugs like Xanax. The report indicated use was nearly twice as prevalent in women than in men and long term use increased from 15% in younger aged patients to more than 31% in older patients. Sedative Risks Heightened In Elderly Patients Benzodiazepines, like Xanax, Valium and Ativan, are powerful sedatives used to treat insomnia and anxiety. The American Geriatrics Society recommends these drugs should generally not be prescribed to older patients. Side effects can include delirium, dementia, impaired cognition and mobility, and increases the risk of falls, which can be especially harmful in older patients. It can also lead to dependence and withdrawal symptoms when patients stop taking the medications. Mark Olfson, lead author of the study, said this is especially a problem for a vulnerable group like elderly patients who can have an increased risk of falls and dementia. This was noted even more as a problem considering most prescriptions for the drugs are received from primary care doctors instead of psychiatrists. This rate decreased with age as well; about 15% of younger patients received their prescriptions from a psychiatrist, while only just under six percent of patients older than 64 received their prescriptions from psychiatrists. Another editorial published in JAMA Psychiatry concerning the topic also focused on the use of these drugs in the U.S. The editorial said drugs like Valium and Xanax are used “predominantly in elderly persons, mostly women, and for long periods of time.” The editorial also said older patients tend to use the medications longer than other patients and said it was not as effective as a treatment for insomnia and anxiety. Nicholas Moore, M.D., Ph.D., author of the editorial, said the effects of drugs like Valium and Xanax tend to wear off after a few weeks and patients experience initial improvement. They then try to stop taking the medication and experience withdrawal symptoms, including the symptoms they are often trying to treat, like insomnia and anxiety. “The usual conclusion is ‘You see, they work. When I stop them, I get worse’,” wrote Moore. “This would not be a major issue if benzodiazepines were truly useful (preferably life-saving) and reasonably risk-free.” Moore says drugs like Xanax should be classified with dangerous and addictive substances, limiting the time it is used and the number of refills allowed. Doctors advise patients who are looking to treat anxiety and insomnia to turn to other treatments, like lifestyle changes, to avoid using Valium. They recommend certain changes, including increasing exercise, exposure to natural light, yoga, drinking warm milk at bedtime and using relaxation tapes. Tags: Dementia, Medication Error, Nursing Home Fall, Valium, Xanax More Lawsuit Stories Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order July 9, 2025 Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer July 9, 2025 Recreational Nitrous Oxide Use Linked to Frostbite Injury Risks, Case Report Warns July 9, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025) Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025) Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order July 9, 2025
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: today) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)
Judge Extends Deadlines in PFAS Lawsuits Over Liver Cancer, Thyroid Cancer (Posted: today) A federal judge has extended deadlines for parties involved in firefighting foam lawsuits to complete discovery and expert reports on liver and thyroid cancer injuries. MORE ABOUT: AFFF LAWSUITPFAS Exposure During Pregnancy Linked to High Blood Pressure in Children: Study (06/26/2025)PFAS Drinking Water Lawsuit Filed by 16 Plaintiffs Over Testicular Cancer, Kidney Cancer, Ulcerative Colitis Side Effects (06/23/2025)AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study (06/13/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)